Home › Funds › PFIZER INC › CRDF

PFIZER INC position in CRDF

CARDIFF ONCOLOGY INC · Health Care

PFIZER INC reported holding 2,411,575 shares of CRDF (CARDIFF ONCOLOGY INC) in its Q3 2026 13F filing — a position valued at US$3.0M, representing 1.82% of its reported portfolio and ranking #10 among its reported holdings. PFIZER INC has disclosed CRDF holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)2.41M sh
Reported value held$2.99M
Portfolio Weight1.82%
First reportedQ4 2024
Last changeHold
Updated2026-11-12

Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR

How PFIZER INC's CRDF position evolved

PFIZER INC first disclosed a stake in CRDF in Q4 2024 at 2,411,575 shares (US$10.5M). Across 8 filings, PFIZER INC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 2,411,575 shares valued at US$3.0M.

Quarter by quarter

QuarterSharesValueChange
Q4 2024 2.41M $10.47M New
Q1 2025 2.41M $7.57M Hold
Q2 2025 2.41M $7.60M Hold
Q3 2025 2.41M $4.97M Hold
Q4 2025 2.41M $6.78M Hold
Q1 2026 2.41M $3.74M Hold
Q2 2026 2.41M $3.01M Hold
Q3 2026 2.41M $2.99M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CRDF and 13F data

CRDF (CARDIFF ONCOLOGY INC) is a Health Care company. 23 other funds we track also report a position in CRDF. Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CRDF

No other tracked fund reports a position in CRDF.

All CRDF fund holders →

FAQ

How long has PFIZER INC held CRDF?

PFIZER INC has disclosed CRDF holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is PFIZER INC's current position in CRDF?

As of Q3 2026, PFIZER INC holds 2.41M shares of CRDF (CARDIFF ONCOLOGY INC), valued at $2.99M, representing 1.82% of its reported portfolio and ranking #10.

Has PFIZER INC been buying or selling CRDF?

In the latest 13F filing (Q3 2026), PFIZER INC held unchanged its position in CRDF.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.